Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats

被引:37
作者
Assie, MB
Koek, W
机构
[1] Neurobiology Division II, Centre de Recherche Pierre Fabre, 81106 Castres Cedex
关键词
8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT); 5-HT reuptake; extracellular 5-HT concentration; microdialysis; hippocampus;
D O I
10.1111/j.1476-5381.1996.tb15749.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The 5-hydroxytryptamine (5-HT)(1A) receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), has been shown to label 5-HT reuptake sites. 2 To study the functional consequences of this property, the effects of 8-OH-DPAT were compared with those of the 5-HT reuptake inhibitors, paroxetine and clomipramine, and of the 5-HT1A receptor agonist flesinoxan, in vitro on 5-HT reuptake, and in vivo on the extracellular concentration of 5-HT by use of microdialysis, in rat hippocampus. Because 5-HT reuptake inhibitors reportedly attenuate the ability of (+)-fenfluramine to increase the extracellular concentration of 5-HT, the possible reversal of these effects by 8-OH-DPAT and by paroxetine were examined. 3 8-OH-DPAT, paroxetine and clomipramine inhibited [H-3]-5-HT reuptake in rat hippocampal synaptosomes (pIC(50): 6.00, 8.41 and 7.00, respectively). In contrast, flesinoxan did not alter 5-HT reuptake (pIC(50) < 5); 4 8-OH-DPAT (10 and 100 mu M), paroxetine (0.1 mu M) and clomipramine (1 mu M), administered through the dialysis probe, significantly increased the hippocampal extracellular concentration of 5-HT. In contrast, flesinoxan (100 mu M) did not alter extracellular 5-HT. Moreover, the effects of 100 mu M 8-OH-DPAT were not blocked by the 5-HT1A receptor antagonist, WAY-100635 (0.16 mg kg(-1), s.c.). 5 The increase in extracellular 5-HT induced by 10 mg kg(-1), i.p., (+)-fenfluramine was prevented not only by 0.1 mu M paroxetine, but also by 100 mu M 8-OH-DPAT. In addition, systemic administration of 10 mg kg(-1), but not 2.5 mg kg(-1), i.p. 8-OH-DPAT attenuated the increase in extracellular 5-HT induced by 2.5 mg kg(-1), i.p., (+)-fenfluramine. 6 These findings suggest that the increase in extracellular 5-HT produced by local administration of 8-OH-DPAT does not involve its S-HT1A receptor agonist properties, but may result, at least in part, from its 5-HT reuptake blocking properties.
引用
收藏
页码:845 / 850
页数:6
相关论文
共 30 条
[1]   INVIVO BRAIN DIALYSIS STUDY OF THE SOMATODENDRITIC RELEASE OF SEROTONIN IN THE RAPHE NUCLEI OF THE RAT - EFFECTS OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN [J].
ADELL, A ;
CARCELLER, A ;
ARTIGAS, F .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) :1673-1681
[2]   [H-3]8-OH-DPAT LABELS THE 5-HYDROXYTRYPTAMINE UPTAKE RECOGNITION SITE AND THE 5-HT1A BINDING-SITE IN THE RAT STRIATUM [J].
ALEXANDER, BS ;
WOOD, MD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (12) :888-891
[3]   (-)-Pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors [J].
Assie, MB ;
Koek, W .
NEUROPHARMACOLOGY, 1996, 35 (02) :213-222
[4]   Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties [J].
Assie, MB ;
Koek, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 304 (1-3) :15-21
[5]  
Assie MB, 1996, BRIT J PHARMACOL, V117, pP92
[6]   DIFFERENTIAL INHIBITION OF SEROTONIN RELEASE BY 5-HT AND NA REUPTAKE BLOCKERS AFTER SYSTEMIC ADMINISTRATION [J].
AUERBACH, SB ;
LUNDBERG, JF ;
HJORTH, S .
NEUROPHARMACOLOGY, 1995, 34 (01) :89-96
[7]   BRAIN MICRODIALYSIS [J].
BENVENISTE, H .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1667-1679
[8]  
BOSKER F, 1994, J NEUROCHEM, V63, P2165
[9]  
Bosker FJ, 1996, J NEUROCHEM, V66, P2546
[10]   THE EFFECT OF 5-HT RECEPTOR LIGANDS ON THE UPTAKE OF [H-3] 5-HYDROXYTRYPTAMINE INTO RAT CORTICAL SYNAPTOSOMES [J].
CHENG, CHK ;
COSTALL, B ;
NAYLOR, RJ ;
RUDD, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 239 (1-3) :211-214